"Suburban Research Associates is a clinical research site devoted to providing individualized care and treatment to our patients. We offer patients the alternative of new advanced treatments while helping the medical research field develop and grow. All of our research studies are FDA approved and participation is on a voluntary basis. Each patient is carefully evaluated and monitored to ensure the highest quality of care throughout the process. At the completion of a study, patients may choose to use our free aftercare services which include around 3 additional months of medication management by our psychiatrist. No insurance required to participate in our studies."

During the past decade, Suburban Research Associates conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 35 clinical trials were completed, i.e. on average, 85.4% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 17 clinical trials were completed. i.e. 130.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Suburban Research Associates" #1 sponsor was "Seaside Therapeutics, Inc." with 7 trials, followed by "Sunovion" with 6 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 5 trials sponsored, "Shire" with 5 trials sponsored and "Janssen Research & Development, LLC" with 5 trials sponsored. Other sponsors include 43 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Suburban Research Associates" #1 collaborator was "Otsuka America Pharmaceutical" with 2 trials as a collaborator, "Camurus AB" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "University of Michigan" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Suburban Research Associates" are "Major Depressive Disorder" (14 trials), "Fragile X Syndrome" (9 trials), "Depressive Disorder, Major" (8 trials), "Depression" (5 trials) and "Schizophrenia" (3 trials). Many other conditions were trialed in "Suburban Research Associates" in a lesser frequency.

Most popular intervention types in "Suburban Research Associates" are "Drug" (72 trials), "Other" (6 trials), "Combination Product" (1 trials), "Device" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (36 trials), "Rapastinel" (5 trials), "Lurasidone" (3 trials), "placebo" (3 trials) and "Arbaclofen" (2 trials). Other intervention names were less common.

The vast majority of trials in "Suburban Research Associates" are 72 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Suburban Research Associates". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 49 completed trials in Suburban Research Associates, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Suburban Research Associates, 1 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".